There are a number of pillars. There's the prevention piece, which we've heard about, and education for physicians and other care providers in looking at alternatives, with different types of pain management initiatives and interventions. There's the treatment for patients who are addicted, whether that's detox, which does not work very well for narcotic and opioid addictions, or whether that's substitution therapy with things like suboxone. Then there are the prescription monitoring programs, which are a very important aspect of this.
Again, addressing any one of these issues will lead to unintended consequences, as we've already heard. We need a national strategy—we've heard a little bit about what that could look like—that will address all of these types of issues. Whether it's the availability of naloxone at the front line, better education of care providers, or harm reduction strategies, it needs to be multi-faceted.